IMVT vs AAPL: Which Stock is Better?
Side-by-side comparison of Immunovant Inc and Apple Inc in 2026
IMVT
Immunovant Inc
$24.50
AAPL
Apple Inc
$258.44
Key Metrics Comparison
| Metric | IMVT | AAPL | Winner |
|---|---|---|---|
| Market Cap | $5.22B | N/A | IMVT |
| P/E Ratio | N/A | 33.01 | AAPL |
| EPS (TTM) | $N/A | $7.89 | AAPL |
| Revenue Growth | 0.0% | 0.2% | AAPL |
| Gross Margin | 0.0% | 47.3% | AAPL |
Analyze IMVT
Full quant analysis
Analyze AAPL
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IMVT or AAPL a better investment?
Comparing IMVT and AAPL: Immunovant Inc has a market cap of $5.22B while Apple Inc has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IMVT and AAPL?
IMVT (Immunovant Inc) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IMVT or AAPL?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IMVT or AAPL?
AAPL has higher revenue growth at 0.2% vs 0.0% for IMVT.
Which company is more profitable: IMVT or AAPL?
Apple Inc (AAPL) has higher gross margins at 47.3% compared to 0.0% for IMVT.
Which is the larger company: IMVT or AAPL?
Immunovant Inc (IMVT) is larger with a market cap of $5.22B compared to N/A for AAPL.
Should I buy IMVT or AAPL in 2026?
Both IMVT and AAPL have investment merit. IMVT trades at $24.50 while AAPL trades at $258.44. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IMVT and AAPL stock?
Key differences: Market Cap ($5.22B vs N/A), P/E Ratio (N/A vs 33.0x), Revenue Growth (0.0% vs 0.2%), Gross Margin (0.0% vs 47.3%).